FDA Adverse Event Injury Summary report: N

TELIGEN

MDR report key: 3043363 · Received April 9, 2013

Report

Report Number
2124215-2013-03782
Event Type
Injury
Date Received
April 9, 2013
Date of Event
January 23, 2013
Report Date
February 13, 2015
Manufacturer
GUIDANT CRM CLONMEL IRELAND
Product Code
LWS
Removal / Correction Number
Z-0026-2014
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

(B)(4). BOSTON SCIENTIFIC HAS ISSUED AN ADVISORY COMMUNICATION REGARDING AN OLDER SUBSET OF COGNIS/TELIGEN DEVICES THAT IS MORE SUSCEPTIBLE TO THIS ANOMALY. SPECIFICALLY, THE PERFORMANCE OF A LOW VOLTAGE CAPACITOR MAY BE COMPROMISED OVER TIME, CAUSING AN INCREASED CURRENT DRAIN THAT CAN LEAD TO PREMATURE BATTERY DEPLETION. THIS PARTICULAR DEVICE WAS INCLUDED IN THE ADVISORY POPULATION.

Additional Manufacturer Narrative · 1

UPON RECEIPT AT OUR QUALITY ASSURANCE LABORATORY, THIS DEVICE WAS THOROUGHLY INSPECTED AND ANALYZED. REVIEW OF THE DEVICE MEMORY CONFIRMED THREE LOW VOLTAGE BATTERY FAULTS (FAULT CODE 1003) HAD BEEN RECORDED. EXTERNAL VISUAL INSPECTION OF THE DEVICE NOTED NO ANOMALIES. AFTER THE TITANIUM CASE WAS OPENED, MICROSCOPIC VISUAL INSPECTION DID NOT REVEAL ANY IRREGULARITIES. THE BATTERY WAS THEN REMOVED, SO THAT AN EXTERNAL POWER SUPPLY COULD BE CONNECTED TO THE DEVICE FOR FURTHER ANALYSIS. A HIGHER THAN NORMAL CURRENT USAGE WAS OBSERVED. ELECTRICAL TESTING ISOLATED THE HIGH CURRENT CONDITION TO TWO COMPROMISED LOW VOLTAGE CAPACITORS THAT ARE CONNECTED TO THE DEVICE'S BATTERY. THIS TYPE OF COMPONENT MALFUNCTION CAN RESULT IN A HIGH CURRENT DRAIN, WHICH OVER TIME CAN RESULT IN PREMATURE BATTERY DEPLETION, AS WAS OBSERVED IN THIS CASE.

Additional Manufacturer Narrative · 1

(B)(4).

Additional Manufacturer Narrative · 1

ENGINEERING REVIEW OF THE DEVICE DATA CONFIRMED A LOW-VOLTAGE FAULT (FAULT CODE 1003) HAD OCCURRED. THERE WERE NO OTHER FAULTS OR RESETS STORED WITHIN DEVICE MEMORY. THERAPY DELIVERY WAS UNAFFECTED. THE DEVICE WAS MALFUNCTIONING SUCH THAT THE BATTERY STATUS INDICATORS WERE NOT REFLECTING THE DEPLETION CONDITION AND WERE THEREFORE INACCURATE. A REVIEW OF THE BATTERY VOLTAGE MEASUREMENT DATA INDICATED THE CURRENT DRAIN WAS CONSISTENT OVER TIME, SO THERE WAS SUFFICIENT RESERVE FOR THE DEVICE TO MAINTAIN NORMAL THERAPY FUNCTIONS FOR TWO WEEKS TIME. TECHNICAL SERVICE'S RECOMMENDATION FOR DEVICE REPLACEMENT WAS CONFIRMED BY ENGINEERING'S REVIEW OF THE DEVICE MEMORY. AS OF TODAY, THE DEVICE REMAINS IMPLANTED PENDING A REPLACEMENT PROCEDURE. THIS REPORT WILL BE UPDATED WHEN THE DEVICE IS EXPLANTED, RETURNED, AND ANALYZED. BOSTON SCIENTIFIC RECEIVED INFORMATION THAT THIS DEVICE WAS EXPLANTED AND REPLACED. THE DEVICE WAS RETURNED AND IS UNDERGOING LABORATORY ANALYSIS. THIS REPORT WILL BE UPDATED WHEN ANALYSIS IS COMPLETE.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT THE PATIENT IMPLANTED WITH THIS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) REPORTED HEARING BEEP TONES FROM THE DEVICE. THE DEVICE WAS INTERROGATED THE NEXT DAY AND FAULT CODE 1003 WAS DISPLAYED ON THE PROGRAMMER. A BOSTON SCIENTIFIC TECHNICAL SERVICES (TS) CONSULTANT WAS CONTACTED AND DISCUSSED THAT THE FAULT CODE WAS AN INDICATOR THAT SOMETHING WAS PREMATURELY DEPLETING THE DEVICE BATTERY, AND THEREFORE THE DEVICE SHOULD BE EXPLANTED AND REPLACED. TS REQUESTED A COPY OF THE DEVICE MEMORY BE SUBMITTED FOR ENGINEERING EVALUATION. NO ADVERSE PATIENT EFFECTS WERE REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
145820 TELIGEN IMPLANTABLE CARDIOVERTER DEFIBRILLATOR LWS GUIDANT CRM CLONMEL IRELAND F110

Patients

Seq Age Sex Outcome Treatment
1 Hospitalization| L| R